Clinical trial

Tranexamic Acid in HIp Fracture Surgery (THIF Study)

NCT00327106 · Centre Hospitalier Universitaire de Saint Etienne, Other · Completed

Key facts

NCT number NCT00327106
Title Tranexamic Acid in HIp Fracture Surgery (THIF Study)
Official title Efficacy of Tranexamic Acid on Perioperative Blood Loss During Hip Fracture Surgery.
Acronym THIF
Lead sponsor Centre Hospitalier Universitaire de Saint Etienne, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hip Fracture
Intervention type Drug
Interventions Tranexamic acid (Exacyl), Placebo
Enrollment 110
Start date Apr 1, 2005
Primary completion Feb 1, 2007
Completion Feb 1, 2007
First posted May 18, 2006
Last update posted Jun 11, 2009
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies